01
Direct answer: what identifies an exact medicine pack?
Use a complete presentation-level description: authorised name, active substance where needed, strength, pharmaceutical form, route of administration, immediate packaging, pack size and the applicable marketing-authorisation or national product identifier. A product code can help, but it should be read with the human-readable presentation rather than used as the only check.
Batch number, expiry date, serial number and available quantity describe physical stock, not the underlying authorised presentation. Keeping reference data and batch data in separate fields makes it easier to see whether a seller has offered the requested pack and whether the evidence actually relates to that stock.
02
Why a medicine name alone is not enough
One medicine name can cover several strengths, pharmaceutical forms, routes, container types and pack sizes. EMA guidance describes the product name in the order “invented name, strength, pharmaceutical form”, and EMA lists centrally authorised presentations separately by EU number, strength, form, route, immediate packaging and pack size.
EU labelling law likewise requires the outer packaging to state particulars including the medicinal-product name, active substances, pharmaceutical form, contents, route where necessary, expiry date, storage precautions, marketing-authorisation number and manufacturer’s batch number. Those fields solve different identification questions and should not be collapsed into a single free-text name.
03
Presentation fields to match before commercial comparison
| Field | What to compare | Mismatch to stop and resolve |
|---|---|---|
| Authorised name and substance | The complete product name and relevant active substance or substances. | Similar brand spelling, a different substance or an unverified translation. |
| Strength | Value, unit and how the strength is expressed, including combination ratios. | Different mg value, concentration or expression per dose, volume or weight. |
| Pharmaceutical form and route | The authorised form and intended route. | Tablet versus capsule, or solution for infusion versus injection. |
| Immediate packaging | Bottle, blister, vial, pre-filled syringe or other authorised container. | Same contents presented in a different container or delivery system. |
| Pack size | Number of units, doses, weight or volume in the sales presentation. | The same strength and form with a different number of units. |
| Presentation identifier | EU presentation number or an applicable national product code. | A code that resolves to another presentation, market or discontinued record. |
Important: A commercial pack quantity means the contents of one presentation. It is different from the number of packs a buyer requests or a seller has available.
04
A six-step exact-pack verification workflow
- 01
Normalise the request
Place name, strength, form, route, pack size and reference code in separate fields; preserve the requester’s original wording for traceability.
- 02
Check an authoritative product record
For centrally authorised medicines, review EMA product information and the list of authorised presentations; use the relevant national authority source for nationally authorised products.
- 03
Match every material field
Do not treat a name or ingredient match as an exact-pack match when strength, form, route, container or pack size differs.
- 04
Request pack evidence
Ask for legible, current evidence that lets the reviewer compare the proposed packaging and identifiers without exposing unnecessary personal data.
- 05
Attach batch-level facts
Record batch, expiry, available quantity, storage profile and serialisation information against the confirmed presentation.
- 06
Escalate unresolved differences
Keep the response out of like-for-like price comparison until ambiguous codes, translations, repackaging or presentation differences are resolved.
05
Codes, safety features and evidence boundaries
Under the EU falsified-medicines framework, applicable packs carry a unique identifier and an anti-tampering device. The unique-identifier system supports authenticity checks through defined supply-chain operations; it does not turn a screenshot, typed serial number or marketplace entry into proof of authenticity.
A reference-code match also does not prove possession, lawful ownership, current availability or suitability for the proposed route. Evidence should be assessed in context by authorised parties. Where repackaging or parallel distribution is involved, check the authorised presentation and the applicable documentation rather than assuming that a changed outer pack is commercially identical.
- Never infer strength, form or pack size from price or brand alone
- Do not merge two presentations because their active ingredient is the same
- Keep source URL, record date and the person or process that performed the check
- Treat unreadable, cropped or internally inconsistent evidence as unresolved
- Recheck the presentation when a supplier substitutes a code, market or package
06
How exact-pack data supports a controlled marketplace
In PharmaBatch, an RFQ or batch offer should attach to one controlled medicine presentation. Structured fields make mismatches visible before participants compare quantity, expiry or the role-specific commercial price and preserve the original requirement in the activity trail.
The platform record is an organisational control, not an approval of a medicine or transaction. Authorisation, counterparty, product, batch, route and documentary checks remain specific to the proposed transaction, and River Pharma GmbH decides whether to accept the wholesale execution role under the published operating model.
07
Frequently asked questions
Is the active ingredient enough to identify a medicine pack?
No. The same ingredient can appear in different strengths, pharmaceutical forms, routes, container types and pack sizes. Match the complete authorised presentation.
Is a product code enough to approve an offer?
No. Resolve the code in an authoritative source and compare the human-readable presentation. A code match does not prove batch possession, availability, authenticity or transaction suitability.
Are pack size and requested quantity the same?
No. Pack size is the authorised content of one presentation, such as 28 tablets. Requested quantity is the number of those packs required in the RFQ.
What should happen when one field does not match?
Pause like-for-like comparison, label the discrepancy and obtain authoritative clarification. Do not silently substitute a different strength, form, route, container or pack size.
08
Primary sources
Regulatory statements on this page are grounded in the following official sources. Always check the current record and guidance for a real transaction.